Literature DB >> 19744125

PCR- and restriction endonuclease-based detection of IDH1 mutations.

Jochen Meyer1, Stefan Pusch, Jörg Balss, David Capper, Wolf Mueller, Arne Christians, Christian Hartmann, Andreas von Deimling.   

Abstract

Hotspot mutations in codon 132 of the gene encoding isocitrate dehydrogenase 1 (IDH1) have emerged as the most frequent DNA alteration in astrocytomas, oligodendrogliomas and oligoastrocytomas. These mutations have been shown to be of significant diagnostic and prognostic value. So far, assessment of IDH1 mutation relied on DNA sequencing techniques. We generated a set of primers suitable for endonuclease-based detection of hotspot mutations in codon 132 of IDH1. This primer set will allow determining these mutations without the need of DNA sequencing. One set of primer sets is designed to detect the presence or absence of IDH1 mutations in codon 132, while the other primer sets individually recognize the R132H, R132C, R132S, R132G and R132L mutations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744125     DOI: 10.1111/j.1750-3639.2009.00327.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  21 in total

Review 1.  Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target.

Authors:  Changcun Guo; Christopher J Pirozzi; Giselle Y Lopez; Hai Yan
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

2.  Mutation analysis of isocitrate dehydrogenase in acute lymphoblastic leukemia.

Authors:  Yiqun Zhang; Hui Wei; Kejing Tang; Dong Lin; Cuiping Zhang; Yingchang Mi; Lin Wang; Cuicui Wang; Min Wang; Jianxiang Wang
Journal:  Genet Test Mol Biomarkers       Date:  2012-07-18

3.  AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma.

Authors:  Alba A Brandes; Gaetano Finocchiaro; Vittorina Zagonel; Michele Reni; Claudia Caserta; Alessandra Fabi; Matteo Clavarezza; Evaristo Maiello; Marica Eoli; Giuseppe Lombardi; Marta Monteforte; Emanuela Proietti; Raffaele Agati; Vincenzo Eusebi; Enrico Franceschi
Journal:  Neuro Oncol       Date:  2016-03-06       Impact factor: 12.300

4.  Prognostic value of IDH1 mutations identified with PCR-RFLP assay in glioblastoma patients.

Authors:  Mateusz Bujko; Paulina Kober; Ewa Matyja; Paweł Nauman; Katarzyna Dyttus-Cebulok; Beata Czeremszyńska; Wiesław Bonicki; Janusz A Siedlecki
Journal:  Mol Diagn Ther       Date:  2010-06-01       Impact factor: 4.074

5.  Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.

Authors:  Midea Gierke; Jan Sperveslage; David Schwab; Rudi Beschorner; Martin Ebinger; Martin U Schuhmann; Jens Schittenhelm
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-27       Impact factor: 4.553

6.  Whole-genomic survey of oligodendroglial tumors: correlation between allelic imbalances and gene expression profiles.

Authors:  Rubén Ferrer-Luna; Lina Núñez; José Piquer; Eugenia Arias; Francisco Dasí; Andrés Cervio; Naomi Arakaki; Gustavo Sevlever; Bernardo Celda; Horacio Martinetto
Journal:  J Neurooncol       Date:  2010-09-05       Impact factor: 4.130

7.  How molecular testing can help (and hurt) in the workup of gliomas.

Authors:  Kenneth Clark; Zoya Voronovich; Craig Horbinski
Journal:  Am J Clin Pathol       Date:  2013-03       Impact factor: 2.493

Review 8.  Molecular diagnostics of gliomas: state of the art.

Authors:  Markus J Riemenschneider; Judith W M Jeuken; Pieter Wesseling; Guido Reifenberger
Journal:  Acta Neuropathol       Date:  2010-08-17       Impact factor: 17.088

9.  Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing.

Authors:  Shipra Agarwal; Mehar Chand Sharma; Prerana Jha; Pankaj Pathak; Vaishali Suri; Chitra Sarkar; Kunzang Chosdol; Ashish Suri; Shashank Sharad Kale; Ashok Kumar Mahapatra; Pankaj Jha
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

Review 10.  IDH mutations in human glioma.

Authors:  Won Kim; Linda M Liau
Journal:  Neurosurg Clin N Am       Date:  2012-05-31       Impact factor: 2.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.